• (PLX AI) – CureVac and GSK Enter into Pandemic Preparedness Contract with German Government.
  • • CureVac says 5-year contract enables production of up to 80 million vaccine doses at short notice
  • • German government reserves domestic manufacturing capacity until 2029 to ensure rapid access to mRNA vaccines developed by CureVac and GSK
  • • Germany will pay CureVac and GSK an annual standby fee after successful completion of the setup period, which requires the companies to maintain manufacturing capacity at constant readiness

Quelle: PLX AI